These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2975203

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hemodynamic, hemorheologic, and hemocoagulative changes after treatment with picotamide in patients affected by peripheral arterial disease (PAD) of the lower limbs.
    Neirotti M, Molaschi M, Ponzetto M, Macchione C, Poli L, Bonino F, Fabris F.
    Angiology; 1994 Feb; 45(2):137-41. PubMed ID: 8129189
    [Abstract] [Full Text] [Related]

  • 3. [The clinico-instrumental evaluation of the efficacy of picotamide in treating chronic obstructive arteriopathies of the lower extremities].
    Canonico V, Ammaturo V, Guarini P, Tedeschi C, Nunziata G, Nappi A, Forgione L, Rengo F.
    Minerva Cardioangiol; 1991 Mar; 39(3):75-80. PubMed ID: 1881558
    [Abstract] [Full Text] [Related]

  • 4. "In vitro" and "ex vivo" effects of picotamide, a combined thromboxane A2-synthase inhibitor and -receptor antagonist, on human platelets.
    Berrettini M, De Cunto M, Parise P, Grasselli S, Nenci GG.
    Eur J Clin Pharmacol; 1990 Mar; 39(5):495-500. PubMed ID: 1963845
    [Abstract] [Full Text] [Related]

  • 5. Ridogrel, a combined thromboxane synthase inhibitor and receptor blocker, decreases elevated plasma beta-thromboglobulin levels in patients with documented peripheral arterial disease.
    Hoet B, Arnout J, Van Geet C, Deckmyn H, Verhaeghe R, Vermylen J.
    Thromb Haemost; 1990 Aug 13; 64(1):87-90. PubMed ID: 2148849
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Antiaggregant effect and tolerance of calcium carbasalate administrated immediately after aorto-coronary bypass. Results of a double-blind versus placebo study].
    Mathieu P, Villemot JP, Stoltz JF, Scheck F, Garnier LF.
    Pathol Biol (Paris); 1996 Jun 13; 44(6):571-80. PubMed ID: 8977914
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Platelet reactivity, fibrinogen and smoking.
    Dotevall A, Kutti J, Teger-Nilsson AC, Wadenvik H, Wilhelmsen L.
    Eur J Haematol; 1987 Jan 13; 38(1):55-9. PubMed ID: 2953626
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Evaluation of arteriolar reactivity and blood coagulation parameters during picotamide treatment].
    Saitta A, Bonaiuto M, Mileto A.
    Clin Ter; 1987 Jan 13; 139(1-2):9-16. PubMed ID: 1837769
    [Abstract] [Full Text] [Related]

  • 20. [Clinical study of picotamide in patients with vascular diseases].
    Speziale F, Taurino M, Colella E, Rizzo L, Fiorani P.
    Recenti Prog Med; 1989 May 13; 80(5):271-5. PubMed ID: 2762664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.